Canada and U.S. economies are expected to grow in 2026, with AI adoption, trade uncertainty and housing risks shaping the ...
During his public inauguration ceremony at New York City Hall on New Year's Day, Mamdani was sworn in by Vermont Sen. Bernie Sanders, a Brooklyn-born independent and fellow democratic socialist who ...
The Print on MSN
How HC order has set into motion probe against meat exporter at centre of 2018 CBI vs CBI feud
Delhi HC has dismissed Qureshi’s argument that an order asking him to provide voice samples amounted to self-incrimination ...
In our news wrap Friday, investigators believe sparklers started the deadly fire inside a Swiss ski resort bar that killed at ...
Crocs (CROX) looks undervalued after a Q3 beat, margin gains, buybacks, and debt cuts. Read here for a detailed investment ...
Venezuelan President Nicolas Maduro revealed during an interview he is ready to talk to U.S. about an agreement to combat drug trafficking.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its fourth quarter and full year 2025 financial and operating results on Friday, January 30, 2026, before the U.S.
President Trump proposes $2,000 "tariff dividend" checks for 2026. Explore the $600B funding gap, legal hurdles, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback